Literature DB >> 10706977

Concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS).

G M Miele1, K M Carpenter, M Smith Cockerham, K Dietz Trautman, J Blaine, D S Hasin.   

Abstract

This study investigated the concurrent and predictive validity of the Substance Dependence Severity Scale (SDSS), a clinician-administered interview designed to assess the severity and frequency of DSM-IV dependence symptoms for a range of substances. A total of 172 (107 males and 66 females) treated substance users participated in the study. Of those, 89% (n=153) received at least one follow-up interview within 1-6 months of an initial assessment. For alcohol, cocaine and heroin, convergent and discriminant validity was supported by significant relationships between SDSS scores at baseline and other baseline measures of substance use consequences, such as the Addiction Severity Index (ASI), as well as significant relationships between SDSS change scores from baseline to follow-up and change scores of other measures of consequences. SDSS scores were significantly associated with time to first post treatment use of alcohol, cocaine and heroin, although the nature of the associations was complex. Scale applications and areas for further study are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10706977     DOI: 10.1016/s0376-8716(99)00110-6

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  18 in total

1.  Selection of a substance use disorder diagnostic instrument by the National Drug Abuse Treatment Clinical Trials Network.

Authors:  Robert F Forman; Dace Svikis; Ivan D Montoya; Jack Blaine
Journal:  J Subst Abuse Treat       Date:  2004-07

2.  The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers.

Authors:  Brian D Kiluk; Jessica A Dreifuss; Roger D Weiss; Jon Morgenstern; Kathleen M Carroll
Journal:  Psychol Addict Behav       Date:  2012-05-28

3.  Issues in designing and implementing a Spanish-language multi-site clinical trial.

Authors:  Lourdes Suarez-Morales; Julie Matthews; Steve Martino; Samuel A Ball; Carmen Rosa; Christine Farentinos; José Szapocznik; Kathleen M Carroll
Journal:  Am J Addict       Date:  2007 May-Jun

4.  Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: experience of the National NeuroAIDS Tissue Consortium.

Authors:  S Morgello; C E Holzer; E Ryan; C Young; M Naseer; S A Castellon; A B Frol; J Hampton Atkinson; B B Gelman; I Grant; E J Singer
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

5.  Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.

Authors:  Diane Warden; Geetha A Subramaniam; Thomas Carmody; George E Woody; Abu Minhajuddin; Sabrina A Poole; Jennifer Potter; Marc Fishman; Michael Bogenschutz; Ashwin Patkar; Madhukar H Trivedi
Journal:  Addict Behav       Date:  2012-05-08       Impact factor: 3.913

6.  Comparison of opiate-primary treatment seekers with and without alcohol use disorder.

Authors:  Bryan Hartzler; Dennis M Donovan; Zhen Huang
Journal:  J Subst Abuse Treat       Date:  2010-07-03

7.  Addiction Severity Index in a chronic pain sample receiving opioid therapy.

Authors:  Kenneth Saffier; Cynthia Colombo; David Brown; Marlon P Mundt; Michael F Fleming
Journal:  J Subst Abuse Treat       Date:  2007-03-21

Review 8.  On beyond urine: clinically useful assessment instruments in the treatment of drug dependence.

Authors:  K M Carroll; B J Rounsaville
Journal:  Behav Res Ther       Date:  2002-11

9.  Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study.

Authors:  Amit Chakrabarti; George E Woody; Margaret L Griffin; Geetha Subramaniam; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2009-11-30       Impact factor: 4.492

10.  Serious adverse events in randomized psychosocial treatment studies: safety or arbitrary edicts?

Authors:  Nancy M Petry; John M Roll; Bruce J Rounsaville; Samuel A Ball; Maxine Stitzer; Jessica M Peirce; Jack Blaine; Kimberly C Kirby; Dennis McCarty; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.